Azithromycin with or without cefixime for suspected or culture-confirmed uncomplicated typhoid fever in Nepal, Bangladesh, and Pakistan (ACT-South Asia): a double-blind, parallel-group, randomised, placebo-controlled, phase 4 trial.

Basnyat B, Adhikari S, Shrestha P, Budhathoki S, Hossain MS, Ahmed N, Dongol S, Maharjan N, Shilpakar O, Gajurel D, Shrestha D, Sharma SK, Shakoor S, Basaula YN, Ojha S, Karki L, Kestelyn E, Wolbers M, Thwaites GE, Ahmed T, Qamar FN, Karkey A, Parry CM, ACT-South Asia Collaborative Group

Open source

DOI: 10.1016/s1473-3099(26)00358-0
Published: 2026 Aug 20
Container: The Lancet. Infectious diseases
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-26-00358-0,
  title = {Azithromycin with or without cefixime for suspected or culture-confirmed uncomplicated typhoid fever in Nepal, Bangladesh, and Pakistan (ACT-South Asia): a double-blind, parallel-group, randomised, placebo-controlled, phase 4 trial.},
  author = {Basnyat B and Adhikari S and Shrestha P and Budhathoki S and Hossain MS and Ahmed N and Dongol S and Maharjan N and Shilpakar O and Gajurel D and Shrestha D and Sharma SK and Shakoor S and Basaula YN and Ojha S and Karki L and Kestelyn E and Wolbers M and Thwaites GE and Ahmed T and Qamar FN and Karkey A and Parry CM and ACT-South Asia Collaborative Group},
  year = {2026},
  journal = {The Lancet. Infectious diseases},
  doi = {10.1016/s1473-3099(26)00358-0},
  url = {https://doi.org/10.1016/s1473-3099(26)00358-0}
}

RIS

TY  - JOUR
TI  - Azithromycin with or without cefixime for suspected or culture-confirmed uncomplicated typhoid fever in Nepal, Bangladesh, and Pakistan (ACT-South Asia): a double-blind, parallel-group, randomised, placebo-controlled, phase 4 trial.
AU  - Basnyat B
AU  - Adhikari S
AU  - Shrestha P
AU  - Budhathoki S
AU  - Hossain MS
AU  - Ahmed N
AU  - Dongol S
AU  - Maharjan N
AU  - Shilpakar O
AU  - Gajurel D
AU  - Shrestha D
AU  - Sharma SK
AU  - Shakoor S
AU  - Basaula YN
AU  - Ojha S
AU  - Karki L
AU  - Kestelyn E
AU  - Wolbers M
AU  - Thwaites GE
AU  - Ahmed T
AU  - Qamar FN
AU  - Karkey A
AU  - Parry CM
AU  - ACT-South Asia Collaborative Group
PY  - 2026
JO  - The Lancet. Infectious diseases
DO  - 10.1016/s1473-3099(26)00358-0
UR  - https://doi.org/10.1016/s1473-3099(26)00358-0
ER  -

APA

B, B., S, A., P, S., S, B., MS, H., N, A., S, D., N, M., O, S., D, G., D, S., SK, S., S, S., YN, B., S, O., L, K., E, K., M, W., GE, T., T, A., FN, Q., A, K., CM, P., & Group, A. A. C. (2026). Azithromycin with or without cefixime for suspected or culture-confirmed uncomplicated typhoid fever in Nepal, Bangladesh, and Pakistan (ACT-South Asia): a double-blind, parallel-group, randomised, placebo-controlled, phase 4 trial.. The Lancet. Infectious diseases. https://doi.org/10.1016/s1473-3099(26)00358-0

Source records

pubmed · retrieved 2026-09-26T22:13:32.798Z